The HMO Cancer Research Network (CRN) was established in 1999 to help the National Cancer Institute maximize the potential of health care delivery systems to address important questions in cancer prevention and control. The CRN consists of an infrastructure and five projects with cover the spectrum of cancer control from prevention to survivorship. Our infrastructure leverages the unique composition and features of the health care delivery systems that comprise this consortium;the 13 health care systems that comprise the CRN consortium are distinguished by their mature automated data systems, commitment to public domain research, and diverse populations. The proposed application is designed to build on the productive cancer research consortium that was established and grown between 1999 and 2006. In this application, we propose to intensify and enhance CRN infrastructure activities that are uniquely positioned to address as yet unsolved issues in cancer care, including: 1) fulfilling the promise of health care informatics to optimize cancer care;2) improving accrual of adult cancer patients to clinical trials;and 3) understanding the drivers which influence the uptake of innovations in cancer care. The proposed CRN infrastructure will emphasize efficient research methods, identify strategies that contribute to high-quality care, and will maintain a patient-centered perspective. Moreover, with a concerted focus on training of junior investigators, the HMO CRN will utilize the human and technical resources available in its health care systems, to permit exploration and exploitation of ways to improve effectiveness of cancer care. Cancer is a very individual experience. We need ways to address both the impact of cancer at a population level, and ways to help individual patients get the care that is best-suited to their unique needs. To this end, the CRN is designed to increase our understanding of the patient-, clinician- and health plan characteristics that lead to the best possible outcomes in cancer prevention and care.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Group Health Cooperative
United States
Zip Code
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Lieu, Tracy A; Ray, G Thomas; Prausnitz, Stephanie R et al. (2017) Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat 163:167-176
Hassett, Michael J; Uno, Hajime; Cronin, Angel M et al. (2017) Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol 49:186-194
Kimmick, Gretchen G; Major, Brittny; Clapp, Jonathan et al. (2017) Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat 163:391-398
Buist, Diana S M; Field, Terry S; Banegas, Matthew P et al. (2017) Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network's Scholars Program. J Cancer Educ 32:283-292
Engmann, Natalie J; Ergas, Isaac J; Yao, Song et al. (2017) Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev 26:1466-1469
Yao, Song; Zhang, Yali; Tang, Li et al. (2017) Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat 161:501-513
Yao, Song; Kwan, Marilyn L; Ergas, Isaac J et al. (2017) Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol 3:351-357
Mazor, Kathleen M; Rubin, Donald L; Roblin, Douglas W et al. (2016) Health literacy-listening skill and patient questions following cancer prevention and screening discussions. Health Expect 19:920-34
Walsh, Kathleen; Ryan, Jamie; Daraiseh, Nancy et al. (2016) Errors and Nonadherence in Pediatric Oral Chemotherapy Use. Oncology 91:231-236

Showing the most recent 10 out of 188 publications